Friday, September 18th 2020 (14:30 - 15:45)

Organised by

Janssen Pharmaceutica


Did you know European start-ups can work with BARDA (a part of the US Government in the US Department of Health and Human Services), too!?

Johnson & Johnson Innovation announced the BLUE KNIGHT™ collaboration to stimulate innovation and incubation of technologies that aim to improve health security and response. Seven JLABS companies from around the world were selected to join as the initial cohort of Blue Knight, two of which are from Europe.

Congratulations to European JLABS companies Genome Biologics and Gabi SmartCare for joining the Blue Knight ranks. Want to watch them prance? Check out the webinars on 9 September and 18 September respectively to learn more about the collaboration with BARDA and about these two selected companies.

A Breath of Fresh Innovation: Advancing Remote Respiratory Monitoring

An apple a day keeps the doctor away, but what if we could keep the doctor away while still being monitored? Gabi SmartCare, a JLABS @ BE company recently selected for Blue Knight, is developing an upper-arm oximeter-based wearable to fit any patient – from premature babies through elderly – that allows healthcare providers to remotely monitor their patients' respiratory outputs using predictive digital analytics.

You might also be interested in the first webinar:

Something Old, Something New: A Disruptive Platform to Repurpose Drugs (September 9, 2020)